#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leiomyosarcoma metastatic Amyotrophic lateral sclerosis gene carrier Hypertriglyceridaemia Anaplastic large cell lymphoma T- and null-cell types Loeys-Dietz syndrome Sickle cell disease Dementia Alzheimer's type Haematological malignancy Plasma cell myeloma Erdheim-Chester disease Aspergillus infection Extraskeletal ossification Ovarian cancer Richter's syndrome Hodgkin's disease refractory More trials…

    Learn about Rare Diseases

    Glycogen storage disease type II – Trials in Disease Testicular leiomyosarcoma – Trials in Disease Adrenocortical carcinoma – Treatment Haemophilia Malignant fibrous histiocytoma – Life with Disease Hairy cell leukaemia – Diagnostics Brain stem glioma Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information Lennox-Gastaut syndrome Synovial sarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    MOLNUPIRAVIR Paeonol Tenecteplase Gs-5245 Resiniferatoxin Vismodegib Ima402 Vepdegestrant OMEGA-3-ACID ETHYL ESTERS 90 Dc-806 Meldonium Caspofungin Acetate Df6002 Omx-0407 Anidulafungin Fitusiran Mexiletine Hydrochloride Sabirnetug Nimorazole Soya-Bean Oil Refined More therapies…

    Learn about Your Condition

    Congenital aplastic anaemia Relapsing multiple sclerosis Muscle strain Peripheral artery restenosis Myositis Macular oedema Colonoscopy Bacteraemia Subdural haematoma Schizophrenia Contusion Migraine with aura Acute HIV infection Cough Arthroscopy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Epcoritamab, Lenalidomide, and Rituximab for Patients with Relapsed and Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    • Central nervous system lymphoma
    Investigated Drugs:
    • Epcoritamab
    • Lenalidomide
    • Rituximab
    France

  • Study on the Safety and Effectiveness of Belantamab Mafodotin for Adults with Primary Immune Thrombocytopenia Previously Treated with Standard Medications

    Recruiting

    2 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Belantamab Mafodotin
    Greece

  • Study on Reducing Hospital Stay in Children with Complicated Appendicitis Using Amoxicillin and Clavulanic Acid

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amoxicillin
    • Clavulanic Acid
    Spain

  • Study on the Safety and Effectiveness of Dexamfetamine Sulfate for Adults with ADHD and Moderate to Severe Depression

    Recruiting

    2 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    • Major depression
    Investigated Drugs:
    • Dexamfetamine Sulfate
    Germany

  • Study on the Effects of Alpha-1 Antitrypsin and Prednisolone in Patients with Severe Alcohol-Related Hepatitis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatitis alcoholic
    Investigated Drugs:
    • Human Alpha1-Proteinase Inhibitor
    • Prednisolone
    Austria

  • Study on [68Ga]FAPI-46 to Detect Lung Fibroblast Activity in COVID-19 Patients with Long-Term Symptoms

    Recruiting

    3 1 1
    Investigated Diseases:
    • Post-acute COVID-19 syndrome
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    The Netherlands
Previous Page
1 … 250 251 252 253 254 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!